Mark J Alles is Director of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 15,095 shares of BMRN, which is worth approximately $991,137. The most recent transaction as insider was on May 23, 2023, when has been sold 4,190 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.1K
0% 3M change
0% 12M change
Total Value Held $991,137

Mark J Alles Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2023
BUY
Grant, award, or other acquisition
-
4,190 Added 21.73%
15,095 Common Stock
Oct 31 2022
BUY
Open market or private purchase
$314,468 $86.75 p/Share
3,625 Added 24.95%
10,905 Common Stock
May 24 2022
BUY
Grant, award, or other acquisition
-
4,980 Added 40.62%
7,280 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
2,300 Added 50.0%
2,300 Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
SYRS
Syros Pharmaceuticals, Inc. Healthcare
MJA

Mark J Alles

Director
San Diego, CA

Track Institutional and Insider Activities on BMRN

Follow BIOMARIN PHARMACEUTICAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN